Common use of Reporting Expenditures Under the Demonstration Clause in Contracts

Reporting Expenditures Under the Demonstration. The following describes the reporting of expenditures under the demonstration: a) In order to track expenditures under this demonstration, the state must report demonstration expenditures through the Medicaid and State Children's Health Insurance Program Budget and Expenditure System (MBES/CBES), following routine CMS-64 reporting instructions outlined in section 2500 of the State Medicaid Manual. All demonstration expenditures must be reported each quarter on separate Forms CMS-64.9 Waiver and/or 64.9P Waiver, identified by the Demonstration project number assigned by CMS (including the project number extension, which indicates the DY in which services were rendered or for which capitation payments were made). b) For monitoring purposes, quarterly cost settlements and pharmaceutical rebates relevant to the demonstration will be allocated (using an approved methodology) to the demonstration populations specified in subparagraph (c) and offset against current quarter waiver expenditures. Demonstration expenditures net of these cost settlement offsets will be reported on Form CMS 64.9

Reporting Expenditures Under the Demonstration. The following describes the reporting of expenditures under the demonstrationDemonstration: a) In order to track expenditures under this demonstrationDemonstration, the state must report demonstration Demonstration expenditures through the Medicaid and State Children's Health Insurance Program Budget and Expenditure System (MBES/CBES), following routine CMS-64 reporting instructions outlined in section 2500 of the State Medicaid Manual. All demonstration Demonstration expenditures must be reported each quarter on separate Forms CMS-64.9 Waiver and/or 64.9P Waiver, identified by the Demonstration project number assigned by CMS (including the project number extension, which indicates the DY in which services were rendered or for which capitation payments were made). b) For monitoring purposes, quarterly cost settlements and pharmaceutical rebates relevant to the demonstration Demonstration will be allocated (using an approved methodology) to the demonstration Demonstration populations specified in subparagraph (c) and offset against current quarter waiver expenditures. Demonstration expenditures net of these cost settlement offsets will be reported on Form CMS 64.9

Reporting Expenditures Under the Demonstration. The following describes the reporting of expenditures under the demonstrationDemonstration: a) In order to track expenditures under this demonstrationDemonstration, the state State must report demonstration Demonstration expenditures through the Medicaid and State Children's Health Insurance Program Budget and Expenditure System (MBES/CBES), following routine CMS-64 reporting instructions outlined in section Section 2500 of the State Medicaid Manual. All demonstration Demonstration expenditures must be reported each quarter on separate Forms CMS-64.9 Waiver and/or 64.9P Waiver, identified by the Demonstration project number assigned by CMS (including the project number extension, which indicates the DY in which services were rendered or for which capitation payments were made). b) For monitoring purposes, quarterly cost settlements and pharmaceutical rebates relevant to the demonstration Demonstration will be allocated (using an approved methodology) to the demonstration Demonstration populations specified in subparagraph (ci) and offset against current quarter waiver expenditures. Demonstration expenditures net of these cost settlement offsets will be reported on Form CMS 64.9

Reporting Expenditures Under the Demonstration. The following describes the reporting of expenditures under the demonstrationDemonstration: a) In order to track expenditures under this demonstrationDemonstration, the state State must report demonstration Demonstration expenditures through the Medicaid and State Children's Health Insurance Program Budget and Expenditure System (MBES/CBES), following routine CMS-64 reporting instructions outlined in section Section 2500 of the State Medicaid Manual. All demonstration Demonstration expenditures must be reported each quarter on separate Forms CMS-64.9 Waiver and/or 64.9P Waiver, identified by the Demonstration project number assigned by CMS (including the project number extension, which indicates the DY in which services were rendered or for which capitation payments were made). b) For monitoring purposes, quarterly cost settlements and pharmaceutical rebates relevant to the demonstration Demonstration will be allocated (using an approved methodology) to the demonstration Demonstration populations specified in subparagraph (c) and offset against current quarter waiver expenditures. Demonstration expenditures net of these cost settlement offsets will be reported on Form CMS 64.9